Palomino Laboratories (PALX) EBT (2023 - 2025)

Palomino Laboratories' EBT history runs 3 years deep, the most recent figure standing at -$1.6 million for Q3 2025.

• In Q3 2025, EBT fell 1383621.55% year-over-year to -$1.6 million; the TTM figure through Sep 2025 stood at -$1.8 million (down 1467.92% YoY), while the FY2024 annual figure was -$145866.0, down 73.78% from the prior year.
• EBT came in at -$1.6 million for Q3 2025 at Palomino Laboratories, down from -$43775.0 in the prior quarter.
• In the past five years, EBT ranged from a high of $116.0 in Q3 2024 to a low of -$1.6 million in Q3 2025.
• A 3-year average of -$218910.4 and a median of -$42863.0 in 2023 frame the typical range for EBT.
• Across the five-year window, EBT surged 100.27% in 2024 and slumped 1383621.55% in 2025, its largest moves.
• Palomino Laboratories' EBT stood at -$32574.0 in 2023, then plunged by 323.53% to -$137962.0 in 2024, then sank by 1063.28% to -$1.6 million in 2025.
• According to Business Quant data, EBT over the past three periods registered -$1.6 million, -$43775.0, and -$25156.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison